King Pharmaceuticals Balance Sheet
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Assets | Quarter Ending Sep 08 |
Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash | 1,304.1 | 1,194.6 | 1,417.3 | 1,366.1 | 1,079.1 |
| Net Receivables | 248.3 | 263.2 | 282.6 | 304.0 | 381.6 |
| Inventories | 92.4 | 104.9 | 110.6 | 110.3 | 161.5 |
| Other Current Assets | 55.4 | 39.2 | 40.3 | 39.2 | 33.0 |
| Total Current Assets | 1,700.1 | 1,601.9 | 1,850.8 | 1,819.7 | 1,655.3 |
| Net Fixed Assets | 257.2 | 264.4 | 264.8 | 257.1 | 264.6 |
| Other Noncurrent Assets | 1,554.5 | 1,591.1 | 1,303.8 | 1,350.1 | 1,458.4 |
| Total Assets | 3,511.8 | 3,457.4 | 3,419.4 | 3,426.8 | 3,378.3 |
| Liabilities and Shareholder's Equity | Quarter Ending Sep 08 |
Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
| Current Liabilities | |||||
| Accounts Payable | 318.1 | 360.9 | 369.8 | 453.1 | 453.1 |
| Short-Term Debt | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 318.1 | 360.9 | 369.8 | 453.1 | 453.1 |
| Long-Term Debt | 400.0 | 400.0 | 400.0 | 400.0 | 400.0 |
| Other Noncurrent Liabilities | 60.8 | 62.0 | 62.3 | 63.0 | 66.6 |
| Total Liabilities | 778.9 | 822.9 | 832.2 | 916.1 | 919.7 |
|
Shareholder's Equity | |||||
| Preferred Stock Equity | -- | -- | -- | -- | -- |
| Common Stock Equity | 2,732.9 | 2,634.6 | 2,587.2 | 2,510.8 | 2,458.6 |
| Total Equity | 2,732.9 | 2,634.6 | 2,587.2 | 2,510.8 | 2,458.6 |
| Shares Outstanding (mil.) | 246.5 | 246.5 | 246.5 | 245.9 | 244.4 |
This data is provided as per license from EDGAR Online
